- Home
- ORLA vs SLNO Comparison
ORLA vs SLNO Comparison
Compare ORLA & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORLA
- SLNO
- Stock Information
- Founded
- ORLA 2007
- SLNO 1999
- Country
- ORLA Canada
- SLNO United States
- Employees
- ORLA N/A
- SLNO N/A
- Industry
- ORLA Precious Metals
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ORLA Basic Materials
- SLNO Health Care
- Exchange
- ORLA Nasdaq
- SLNO Nasdaq
- Market Cap
- ORLA 3.8B
- SLNO 3.8B
- IPO Year
- ORLA N/A
- SLNO 2014
- Fundamental
- Price
- ORLA $11.50
- SLNO $49.71
- Analyst Decision
- ORLA Buy
- SLNO Strong Buy
- Analyst Count
- ORLA 2
- SLNO 10
- Target Price
- ORLA $14.50
- SLNO $112.50
- AVG Volume (30 Days)
- ORLA 1.9M
- SLNO 1.7M
- Earning Date
- ORLA 11-11-2025
- SLNO 11-05-2025
- Dividend Yield
- ORLA N/A
- SLNO N/A
- EPS Growth
- ORLA N/A
- SLNO N/A
- EPS
- ORLA 0.07
- SLNO N/A
- Revenue
- ORLA $596,487,000.00
- SLNO $32,656,999.00
- Revenue This Year
- ORLA $170.92
- SLNO N/A
- Revenue Next Year
- ORLA $23.64
- SLNO $175.39
- P/E Ratio
- ORLA $162.20
- SLNO N/A
- Revenue Growth
- ORLA 116.83
- SLNO N/A
- 52 Week Low
- ORLA $3.81
- SLNO $41.50
- 52 Week High
- ORLA $12.91
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- ORLA 54.11
- SLNO 22.26
- Support Level
- ORLA $10.56
- SLNO $50.63
- Resistance Level
- ORLA $12.91
- SLNO $72.99
- Average True Range (ATR)
- ORLA 0.57
- SLNO 4.32
- MACD
- ORLA 0.09
- SLNO -1.60
- Stochastic Oscillator
- ORLA 40.07
- SLNO 3.34
About ORLA Orla Mining Ltd.
Orla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds three gold projects; the Camino Rojo gold and silver project in Zacatecas State, Musselwhite gold mine project located in Ontario and the South Railroad projects in Nevada, USA, and the Cerro Quema gold project in Panama. It conducts business activities in Mexico, Panama, the United States, and Canada.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.